NASDAQ
Finch Therapeutics Group, Inc. (FNCH) has a eps (diluted) of $-8.64 as of Tuesday, December 31, 2024. Diluted EPS accounts for all potential shares from stock options and convertible securities, providing a more conservative earnings-per-share measure.
No price data available for this timeframe.